We are live on ! Find out more
ZYBT

Zhengye Biotechnology Holding
ZYBT

9 hedge funds and large institutions have $2.51M invested in Zhengye Biotechnology Holding in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

34,830% more capital invested

Capital invested by funds: $7.19K → $2.51M (+$2.5M)

200% more funds holding

Funds holding: 3 → 9 (+6)

0.89% more ownership

Funds ownership: 0% → 0.89% (+0.89%)

Holders
9
Holders Change
+6
Holders Change %
+200%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$1.54M
2
UBS Group
UBS Group
Switzerland
+$1.22M
3
Invesco
Invesco
Georgia
+$292K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$231K
5
TRCT
Tower Research Capital (TRC)
New York
+$26.5K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$1.16M +$1.54M +193,982 New
UBS Group
2
UBS Group
Switzerland
$922K +$1.22M +153,223 +11,887%
Invesco
3
Invesco
Georgia
$220K +$292K +36,839 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$174K +$231K +29,068 New
TRCT
5
Tower Research Capital (TRC)
New York
$19.9K +$26.5K +3,335 +333,500%
Morgan Stanley
6
Morgan Stanley
New York
$14.5K +$19K +2,390 +5,196%
BNP Paribas Financial Markets
7
BNP Paribas Financial Markets
France
$1.56K +$2.08K +262 New
Bank of America
8
Bank of America
North Carolina
$436 +$580 +73 New
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
– +$270 +34 New

ZYBT Hedge Fund Activity: Q2 2025 in Review

9 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in Zhengye Biotechnology Holding (ZYBT) for Q2 2025, worth a combined $2.51M — up 34,830% from $7.19K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ZYBT positions and 0 closed out — a net gain of 6 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $1.54M.

  • 9 institutional investors held Zhengye Biotechnology Holding (ZYBT) as of Q2 2025, up from 3 in Q1 2025.
  • Funds reported $2.51M of Zhengye Biotechnology Holding stock for Q2 2025, up 34,830% quarter-over-quarter.
  • 6 funds opened new Zhengye Biotechnology Holding positions in Q2 2025 and 0 closed out, a net change of +6 holders.
  • The largest Zhengye Biotechnology Holding buyer in Q2 2025 was Jane Street, an estimated $1.54M added.

Based on aggregated 13F filings for Q2 2025.